Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 32.75
-0.35 (-1.06%)
At close: Jan 21, 2026
Level Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 80.78 | 64.81 | 62.91 | 58.47 | 68.18 | 58.04 | Upgrade |
Depreciation & Amortization | 22.12 | 21.22 | 19.72 | 19.5 | 19.79 | 20.83 | Upgrade |
Loss (Gain) From Sale of Assets | - | -0.02 | -0.1 | -0.08 | 0.13 | -0.09 | Upgrade |
Loss (Gain) From Sale of Investments | -8.01 | - | - | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | -0.05 | -0.06 | 0.24 | - | - | 0.25 | Upgrade |
Other Operating Activities | 1.63 | -0.19 | 2 | -3.7 | 1.37 | 1.45 | Upgrade |
Change in Accounts Receivable | -14.89 | -2 | 6.5 | -22.98 | 56.35 | -16.23 | Upgrade |
Change in Inventory | 10.29 | -9.24 | -15.39 | -17.53 | 7.36 | 13.09 | Upgrade |
Change in Accounts Payable | -9.64 | 2.55 | -14.8 | 17.36 | -25.79 | -15.03 | Upgrade |
Change in Unearned Revenue | -8.97 | -1.11 | 3.21 | 23.04 | 18.53 | 18.43 | Upgrade |
Change in Other Net Operating Assets | 6.58 | -11.86 | 5.91 | -9 | 10.03 | 2.48 | Upgrade |
Operating Cash Flow | 79.83 | 64.1 | 70.21 | 65.07 | 155.95 | 83.23 | Upgrade |
Operating Cash Flow Growth | 42.66% | -8.71% | 7.90% | -58.27% | 87.38% | -23.66% | Upgrade |
Capital Expenditures | -243.5 | -223.68 | -7.67 | -6.74 | -9.16 | -2.54 | Upgrade |
Sale of Property, Plant & Equipment | - | 0.03 | 0.23 | 0.15 | - | 0.29 | Upgrade |
Other Investing Activities | 25.11 | 7.54 | -3.46 | -3.6 | 0.37 | -0.38 | Upgrade |
Investing Cash Flow | -218.39 | -216.11 | -10.9 | -10.19 | -8.79 | -2.64 | Upgrade |
Long-Term Debt Repaid | - | -4.57 | -3.12 | -2.69 | -2.66 | -2.55 | Upgrade |
Net Debt Issued (Repaid) | -4.68 | -4.57 | -3.12 | -2.69 | -2.66 | -2.55 | Upgrade |
Common Dividends Paid | -60.58 | -55.17 | -55.17 | -61.66 | -51.93 | -42.19 | Upgrade |
Other Financing Activities | - | -2.88 | 2.88 | - | 0.06 | 0.04 | Upgrade |
Financing Cash Flow | -65.26 | -62.62 | -55.4 | -64.35 | -54.52 | -44.69 | Upgrade |
Net Cash Flow | -203.81 | -214.62 | 3.91 | -9.46 | 92.64 | 35.9 | Upgrade |
Free Cash Flow | -163.67 | -159.58 | 62.54 | 58.33 | 146.8 | 80.69 | Upgrade |
Free Cash Flow Growth | - | - | 7.22% | -60.26% | 81.93% | -24.31% | Upgrade |
Free Cash Flow Margin | -21.73% | -21.82% | 9.47% | 9.84% | 21.67% | 12.00% | Upgrade |
Free Cash Flow Per Share | -5.01 | -4.89 | 1.92 | 1.79 | 4.49 | 2.48 | Upgrade |
Cash Interest Paid | 0.22 | 0.28 | 0.33 | 0.35 | 0.38 | 0.43 | Upgrade |
Cash Income Tax Paid | 16.61 | 16.26 | 13.74 | 17.91 | 15.35 | 13.05 | Upgrade |
Levered Free Cash Flow | -184.43 | -175.08 | 40.7 | 40.94 | 127.71 | 63.75 | Upgrade |
Unlevered Free Cash Flow | -184.29 | -174.9 | 40.91 | 41.15 | 127.95 | 64.02 | Upgrade |
Change in Working Capital | -16.63 | -21.66 | -14.56 | -9.11 | 66.48 | 2.75 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.